On Thursday, Unilever N.V. (ADR) (NYSE:UN)’s shares inclined 0.67% to $40.68.
Unilever has been named as a leader of the Food, Beverage and Tobacco Industry Group in the 2015 Dow Jones Sustainability Index (DJSI) results. It is one of only 24 companies to be named as Industry Group Leaders.
Unilever achieved an overall score of 92 out of a possible 100, an enhance from 90 in 2014.
Unilever led, or jointly led, the industry in eight of the 23 Food Products criteria, counting: Innovation Administration; Strategy for Emerging Markets; Climate Strategy; Packaging; and Talent Attraction & Retention.
The DJSI is a globally recognized independent benchmark that measures proven company performance across material economic, environmental and social criteria. Unilever has been a member of the DJSI World Index since it began in 1999.
Unilever N.V. operates as a fast-moving consumer goods company in the Americas, Europe, Asia, Australasia, Africa, the Middle East, Turkey, Russia, Ukraine, and Belarus. The company operates through Personal Care, Foods, Refreshment, and Home Care segments. The Personal Care segment offers skincare and haircare products, deodorants, and oral care products.
Vonage Holdings Corp.(NYSE:VG)’s shares gained 0.32% to $6.22.
Vonage declared that it has been positioned by Gartner®, Inc. in the Visionaries quadrant of the 2015 Magic Quadrant for Unified Communications as a Service, Worldwide. In this Magic Quadrant, Gartner evaluated 20 UC solutions providers based on “Ability to Execute” and “Completeness of Vision” within the market.
Mr. Masarek continued, “Vonage provides a reliable and secure platform that delivers our robust set of UCaaS voice and data services in the cloud at Quality of Service (QoS) levels over both private net operates and customers’ existing broadband connections. Vonage’s technology also integrates our communications platform into Google apps, Microsoft Lync as a Service and CRM applications such as Salesforce, Zoho and Clio. Combined, these services and technologies uniquely position Vonage to serve the full spectrum of communications needs for business from SMB to enterprise.”
On August 31, 2015, Vonage attained iCore Netoperates, a privately-held UCaaS provider, which placed in the 2015 Magic Quadrant in the Niche Players category.
Vonage Holdings Corp. provides unified communications as a service solutions connecting people through cloud-connected devices worldwide. The company offers home telephone replacement services to residential customers through various service plans with basic features, such as voicemail, call waiting, call forwarding, simulring, visual voicemail, and extensions, in addition to area code selection, virtual phone number, and Web-enabled voicemail.
At the end of Thursday’s trade, NOW Inc(NYSE:DNOW)‘s shares surged 2.93% to $17.24.
NOW Inc. (DNOW) has planned a conference call to talk about the results for the third quarter of 2015 on Tuesday, November 3, 2015 at 8:00 am (US Central Time). Financial results for the third quarter of 2015 are predictable to be released that morning before the market opens.
NOW Inc. distributes energy and industrial products in the United States, Canada, and internationally. It offers consumable maintenance, repair, and operating supplies; and pipes, valves, fittings, flanges, electrical products, artificial lift solutions, mill tools, safety supplies, and spare parts, in addition to provides application systems and parts integration, optimization solutions, and after-sales support services.
Keryx Biopharmaceuticals(NASDAQ:KERX), ended its Thursday’s trading session with -3.13% loss, and closed at $4.64.
Keryx Biopharmaceuticals, Inc, (KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease, declared that corporate presentations would be delivered at the following investor conference.
Ladenburg Thalmann 2015 Healthcare Conference
Presenter: Scott Holmes, Chief Financial Officer.
Presentation Date: Tuesday, September 29, 2015.
Presentation Time: 1:00 p.m. ET.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, in addition to treats iron deficiency anemia.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
